MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.3B
This Quarter Return
+8.9%
1 Year Return
+46.22%
3 Year Return
+108.24%
5 Year Return
–
10 Year Return
–
AUM
$14.6B
AUM Growth
+$14.6B
(-17%)
Cap. Flow
-$4.02B
Cap. Flow
% of AUM
-27.6%
Top 10 Holdings %
Top 10 Hldgs %
20.74%
Holding
1,653
New
314
Increased
216
Reduced
349
Closed
768
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$213M |
| 2 |
Medtronic
MDT
|
$130M |
| 3 |
Charter Communications
CHTR
|
$105M |
| 4 |
Merck
MRK
|
$99.9M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$96.5M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$230M |
| 2 |
Baidu
BIDU
|
$120M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$112M |
| 4 |
Constellation Brands
STZ
|
$111M |
| 5 |
Abbott
ABT
|
$110M |
Sector Composition
| 1 | Healthcare | 31.1% |
| 2 | Technology | 16.39% |
| 3 | Industrials | 11.22% |
| 4 | Consumer Discretionary | 9.86% |
| 5 | Financials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.77T
| $487M | 3.34% | 4,254,065 -821,310 | -16% | -$93.9M |
|
2
Zoetis
ZTS
$69.3B
| $385M | 2.64% | 4,202,241 +1,034,161 | +33% | +$94.7M |
|
|
ABMD
3
DELISTED
Abiomed Inc
ABMD
| $310M | 2.13% | 690,160 +214,655 | +45% | +$96.5M |
|
4
Boston Scientific
BSX
$156B
| $282M | 1.94% | 7,333,396 -1,615,233 | -18% | -$62.2M |
|
5
Global Payments
GPN
$21.5B
| $275M | 1.89% | 2,162,102 +655,495 | +44% | +$83.5M |
|
6
UnitedHealth
UNH
$281B
| $272M | 1.87% | 1,022,572 +39,318 | +4% | +$10.5M |
|
7
S&P Global
SPGI
$167B
| $271M | 1.86% | 1,387,773 +81,878 | +6% | +$16M |
|
|
8
Alphabet (Google) Class A
GOOGL
$2.57T
| $270M | 1.85% | 223,435 +176,870 | +380% | +$213M |
|
9
Pfizer
PFE
$141B
| $236M | 1.62% | 5,365,866 +1,048,787 | +24% | +$46.2M |
|
10
CoStar Group
CSGP
$37.9B
| $231M | 1.58% | 548,194 +77,373 | +16% | +$32.6M |
|
|
11
Merck
MRK
$210B
| $228M | 1.57% | 3,213,988 +1,408,204 | +78% | +$99.9M |
|
12
Sealed Air
SEE
$4.78B
| $227M | 1.56% | 5,660,228 +326,156 | +6% | +$13.1M |
|
13
Quest Diagnostics
DGX
$20.3B
| $226M | 1.55% | 2,092,866 -565,264 | -21% | -$61M |
|
14
Danaher
DHR
$147B
| $176M | 1.21% | 1,622,939 +306,936 | +23% | +$33.4M |
|
15
Agilent Technologies
A
$35.7B
| $174M | 1.2% | 2,471,337 -493,983 | -17% | -$34.8M |
|
16
Carlisle Companies
CSL
$16.5B
| $172M | 1.18% | 1,415,107 -328,709 | -19% | -$40M |
|
17
Equifax
EFX
$30.3B
| $169M | 1.16% | 1,291,279 +403,174 | +45% | +$52.6M |
|
18
Cintas
CTAS
$84.6B
| $166M | 1.14% | 838,445 +182,213 | +28% | +$36M |
|
19
Visa
V
$683B
| $159M | 1.09% | 1,060,305 +325,768 | +44% | +$48.9M |
|
20
Cigna
CI
$80.3B
| $159M | 1.09% | 761,135 +344,859 | +83% | +$71.8M |
|
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $155M | 1.07% | 804,761 -583,039 | -42% | -$112M |
|
|
BERY
22
DELISTED
Berry Global Group, Inc.
BERY
| $154M | 1.06% | 3,188,758 -601,128 | -16% | -$29.1M |
|
23
Humana
HUM
$36.5B
| $151M | 1.04% | 445,234 +155,010 | +53% | +$52.5M |
|
24
Roper Technologies
ROP
$56.6B
| $150M | 1.03% | 507,364 +124,939 | +33% | +$37M |
|
25
US Foods
USFD
$17.5B
| $137M | 0.94% | 4,443,836 +981,494 | +28% | +$30.2M |
|